Bessemer »

Dianthus Therapeutics shares owned by Bessemer

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Bessemer from 13F filings

Historical chart of Bessemer investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Bessemer consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Bessemer

Quarter filed Position value Share count Share price at filing
2023-12-31 $154k 15k 10.39
2023-09-30 $203k 15k 13.69

More positions owned by Bessemer

Microsoft Corp SC (MSFT)
Apple SC (AAPL)
Amazon.com SC (AMZN)
Alphabet Inc Class C SC (GOOG)
Nvidia Corp SC (NVDA)
Visa SC (V)
Jpmorgan Chase & Co SC (JPM)
Meta Platforms SC (META)
Unitedhealth Group SC (UNH)
Oracle Corp SC (ORCL)
Broadcom SC (AVGO)
Carnival Corp Cl A SC (CCL)
Cencora SC (COR)
Chevron Corp SC (CVX)
Costco Whsl Corp SC (COST)

View all positions for Bessemer

Top funds holding Dianthus Therapeutics

FMR
Bain Capital Life Sciences Investors
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
VR Adviser
Octagon Capital Advisors
5AM Venture Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Henderson Group
Point72 Asset Management
Adage Capital Partners GP
Millennium Management
Tang Capital Management

View all funds holding Dianthus Therapeutics